share_log

Monte Rosa Therapeutics Q4 EPS $(0.58) Misses $(0.33) Estimate; Cash Balance Of $237M Is Expected To Provide Cash Runway Into First Half Of 2026

Moomoo 24/7 ·  Mar 14 07:12

Monte Rosa Therapeutics (NASDAQ:GLUE) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimate of $(0.33) by 75.76 percent. This is a 7.94 percent increase over losses of $(0.63) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment